Two promoters of drug firm Jubilant Life Sciences has sold 3 per cent stake in the company for over Rs 455 crore, through open market transactions. The promoters are Jubilant Consumer and Jubilant Advisors LLP.
Jubilant Consumer has disposed of 27.36 lakh shares, amounting to 1.72 per cent stake in the company at an average price of Rs 914 per scrip, valuing the transaction at Rs 250.07 crore. The Jubilant Advisors LLP has sold 22.38 lakh shares, or 1.41 per cent stake in the drug firm at a price of Rs 917.43 apiece, translating into a transaction of Rs 205.32 crore.
Among the buyers of the shares was Copthall Mauritius Investment, which purchased 27.50 lakh shares for Rs 251.35 crore.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: